HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹206 Cr | ₹210 Cr | ₹277 Cr | ₹195 Cr | ₹222 Cr |
What is the latest Net Current Assets ratio of HIKAL ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹206 Cr |
| Mar2024 | ₹210 Cr |
| Mar2023 | ₹277 Cr |
| Mar2022 | ₹195 Cr |
| Mar2021 | ₹222 Cr |
How is Net Current Assets of HIKAL Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹206 Cr | -1.95 | |
| Mar2024 | ₹210 Cr | -24.32 | |
| Mar2023 | ₹277 Cr | 42.22 | |
| Mar2022 | ₹195 Cr | -12.05 | |
| Mar2021 | ₹222 Cr | - | |
Compare Net Current Assets of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,868.6 Cr | -2.5% | -7.1% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,596.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2.5% |
-7.1% |
-38.8% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses